Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma交叉队列分析确定了基于免疫检查点的特征，以预测神经母细胞瘤的临床结果JOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62023-05-024OAAI
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ? Bevacizumab versus FOLFOX ? Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)CLINICAL CANCER RESEARCHIF10.22022-08-0518OAAI
Association of Plasma Epstein-Barr Virus DNA With Outcomes for Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Receiving Anti-Programmed Cell Death 1 ImmunotherapyJAMA NETWORK OPENIF9.72022-03-0125OAAI
Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women A Randomized Clinical TrialJAMA NETWORK OPENIF9.72021-04-0912OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向